Skip to content

Ionis med added to Aetna precertification list

March 1, 2017

Ionis Pharmaceuticals Inc IONS shares were trading up 6.61 percent Tuesday on news that Aetna Inc AET added Spinraza — a drug developed by Ionis and licensed by Biogen Inc BIIB — to its precertification list.

However, an Aetna representative told Benzinga the “appearance on this list does not indicate one way or the other what the clinical policy will be.”


“As with all new FDA-approved products, we will conduct a full clinical review of Spinraza (nusinersen) to determine our clinical coverage policy,” the spokesperson said. “We have not yet completed this review.”

In October, Benzinga received a similar response from Aetna regarding Sarepta Therapeutics Inc SRPT’s Exondys 51, whose coverage was confirmed two months later.


From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: